Welcome to our dedicated page for Logiq news (Ticker: LGIQ), a resource for investors and traders seeking the latest updates and insights on Logiq stock.
Company Overview
Logiq Inc, headquartered in New York, New York, is a multifaceted technology company that originally built its reputation by developing innovative e-commerce, m-commerce, marketing technology (martech), and fintech enablement solutions for mobile users. The company empowers small and medium-sized businesses (SMBs) through its platform-as-a-service (PaaS) solution, Applogiq, which enables the rapid creation and deployment of native mobile applications across multiple languages and international markets, including dynamic emerging regions in Southeast Asia. In its foundational market, Logiq Inc brings advanced digital customer acquisition tools and AI-driven insights into the realms of e-commerce and mobile advertising, setting a strong benchmark in the digital transformation landscape.
Core Digital Solutions and Product Portfolio
At the heart of Logiq Inc is a suite of comprehensive solutions designed to streamline and optimize digital engagement. Applogiq serves as a robust platform for businesses to design, test, and launch native mobile applications efficiently. The company also offers Datalogiq, an artificial intelligence (AI) powered data engine that captures consumer intent, thereby boosting lead generation, engagement, and conversion rates for brands and enterprises. Complementing these offerings, Logiq Inc has developed additional products such as LogiqX, another AI-driven tool that delivers high-quality consumer insights, and Paylogiq, a mobile payment e-wallet solution designed to simplify transactions for users. Furthermore, Gologiq extends the company’s reach into the food delivery segment, integrating digital ordering with location-based services.
Technological Innovation and Market Position
Logiq Inc stands apart in a competitive landscape by combining robust mobile application development with advanced AI algorithms that drive actionable consumer data. The company’s innovative approach enhances traditional digital advertising by ensuring that every marketing effort is refined through data-driven insights, thereby enabling brands to better connect with their target audience. This dual focus on digital commerce and marketing technology underpins a dynamic business model that balances technical prowess with practical, scalable solutions for businesses of varying sizes.
Diversification into Biotech and Medical Devices
In a significant strategic pivot, Logiq Inc has diversified its operations by venturing into the biotech and medical devices sectors. By acquiring companies with expertise in cell and gene therapy and medical innovation, the company is leveraging its expertise in data and AI to create synergies between digital technology and health solutions. The acquisition of entities specializing in cell-based therapies and medical device innovations, such as advanced vital sign monitoring solutions and remote patient monitoring platforms, underscores Logiq Inc's commitment to disruptive technological advances beyond its traditional domains. This strategic diversification not only broadens the company's product portfolio but also positions it to contribute to groundbreaking treatments and solutions in the health sector.
Business Model and Revenue Generation
Logiq Inc generates revenue through multiple streams that reflect its diversified approach. Its core business involves providing platform-based solutions to SMBs, enabling cost-effective and efficient mobile application development and digital customer acquisition. Through subscriptions, licensing, and performance-based marketing solutions, the company leverages its AI-powered tools to drive monetization for its clients. In parallel, its targeted acquisitions in biotech and medical devices create additional avenues for revenue by tapping into emerging markets and innovative research sectors. These diversified income streams not only buffer against market volatility in a single domain but also reinforce Logiq Inc’s position as a versatile, tech-driven enterprise.
Competitive Landscape and Strategic Positioning
Operating in both the digital technology and health innovation sectors, Logiq Inc navigates a competitive ecosystem that includes established players in mobile technology, digital advertising, fintech, as well as emerging biotech firms. The company differentiates itself through its integrated approach that combines the rapid deployment of digital solutions with cutting-edge AI analytics, and its strategic acquisitions that expand its engagement into health technology. Its considered blend of digital commerce expertise and innovative health solutions provides a competitive edge, positioning the company as a unique entity that bridges technology and medical innovation. Investors and market analysts recognize Logiq Inc’s ability to intersect these varied sectors with precision and robust technological infrastructure.
Commitment to Innovation and Market Adaptability
Logiq Inc maintains a strong commitment to continuous innovation, ensuring its product offerings evolve in response to shifting market demands and technological advances. Its approach to integrating data analytics with mobile technology sets a distinctive standard in digital customer acquisition. At the same time, its expansion into the biotech and medical devices realms reflects a broader vision of applying advanced technological solutions to complex challenges in health care, with a focus on areas such as cell and gene therapy, longevity treatments, and advanced patient monitoring systems. The company’s adaptability is evident in its capacity to reallocate resources and reorient strategic priorities in order to maintain relevance and competitive strength in multiple high-growth industries.
Conclusion
In summary, Logiq Inc represents a robust confluence of digital marketing technology and innovative health solutions. By capitalizing on its expertise in e-commerce, martech, and fintech along with strategic forays into biotech and medical device innovation, the company continues to evolve its business model to meet diverse market needs. Its comprehensive suite of mobile application development platforms and AI-powered marketing solutions, bolstered by a dynamic diversification strategy, establishes Logiq Inc as a multifaceted player capable of driving digital transformation and medical innovation concurrently. Whether through enhancing digital customer engagement or pioneering new pathways in health technology, Logiq Inc remains an informative case study in the effective integration of advanced technology into practical, revenue-generating business models.
Logiq Inc (OTC:LGIQ) has announced the launch of AVR BIOVET™, a new organic feed additive through its veterinary division MedLabs/Amino Medic The product features nano particles of copper, essential amino acids, vitamins, and probiotics designed to maximize growth potential and improve animal health.
AVR BIOVET™ aims to supplement or replace antibiotics in breeding cycles, making products organic and Glatt Kosher. In testing with pig farms by BIOTEC Group, the product showed an 80% survival rate among early-born piglets that typically have only a 10% survival rate. The product is bioavailable, non-accumulating, and eliminates from the body within 72 hours.
The company is seeking FDA and USDA approvals before manufacturing. Additionally, Logiq announced the initiation of a CEO search, with Brent Suen transitioning from his role. The R&D team, led by Dr. Mark Litvak in Tel Aviv, will continue developing solutions for both animal and human health applications.
Logiq, Inc. (OTC PINK:LGIQ) has announced a definitive agreement to acquire EVIMATE, a medical device innovation company, for $5 million. This acquisition marks Logiq's entry into the medical device sector. EVIMATE specializes in advanced vital sign monitoring products that utilize AI technology for comprehensive health metric tracking and predictive analytics.
EVIMATE's solution includes next-generation devices and a user-friendly app that continuously monitors key health indicators such as temperature, heart rate, ECG, blood pressure, oxygen levels, and glucose levels. The system is designed for Remote Patient Monitoring (RPM), providing real-time insights and alerts to healthcare providers, caregivers, and family members.
Additionally, EVIMATE has developed an automotive healthcare system for monitoring driver vitals, featuring sensors in the driver's seat and steering wheel to collect vital signs like heart functions, respiratory rate, stress level, and blood oxygen level. All devices mentioned will require FDA regulatory approvals and additional patent filings for IP protection.
Logiq, Inc. (OTC:LGIQ) has announced a definitive agreement to acquire MedLab Essentials, , a leader in cell and gene therapy innovation, in a deal valued at $100 million. The acquisition will be executed through a share exchange, with MedLab becoming a wholly owned subsidiary of Logiq. Key highlights include:
1. Logiq shareholders will retain 15% post-transaction
2. The combined entity aims to uplist to Nasdaq, CBOE, or NYSE
3. A substantial capital raise is planned by the end of 2024
4. This marks Logiq's first step in a series of biotech acquisitions targeting a cumulative value over $750 million
This strategic move signifies Logiq's diversification into the biotech sector, particularly focusing on cell and gene therapy assets.
Logiq has signed a binding letter of intent to acquire MedLab Essentials for $100 million in a share exchange deal. MedLab will become a wholly-owned subsidiary, with its executives joining Logiq's senior management.
This acquisition diversifies Logiq into the biotech sector and aims for a Nasdaq, CBOE, or NYSE uplisting by Q3 2024. Post-transaction, Logiq shareholders will retain 15% of the company. This is part of a broader strategy to expand into biotech and cell and gene therapy, targeting a cumulative value exceeding $750 million.
FAQ
What is the current stock price of Logiq (LGIQ)?
What is the market cap of Logiq (LGIQ)?
What core solutions does Logiq Inc offer?
How does Logiq Inc integrate AI into its offerings?
Which markets does Logiq Inc serve?
How is Logiq Inc diversifying its business model?
What distinguishes Applogiq from other mobile app development platforms?
How does Logiq Inc maintain its competitive advantage?
What kind of revenue streams does Logiq Inc utilize?
